AI assistant
SERKO LIMITED — Director's Dealing 2025
Aug 4, 2025
65804_rns_2025-08-04_1986f267-9cc7-4de8-b415-7be857154301.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [134 x 34] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
==> picture [549 x 646] intentionally omitted <==
----- Start of picture text -----
To NZX Limited; and
Name of listed issuer: Serko Limited
Date this disclosure made: 4 August 2025
Date of last disclosure: 29 November 2024
Director or senior manager giving disclosure
Full name(s): Robert Clyde McConaghy
Name of listed issuer: Serko Limited
Name of related body corporate (if applicable): Not applicable
Position held in listed issuer: Previous Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary shares in Serko Limited
Nature of the affected relevant interest(s): Registered holder and beneficial owner
of shares by virtue of Mr McConaghy
being a trustee (and beneficiary) of the
Portofino Trust.
For that relevant interest-
Number held in class before acquisition or disposal: 153,003.00
Number held in class after acquisition or disposal: 143,003.00
Current registered holder(s): Mr McConaghy as trustee for Portofino
Trust
Registered holder(s) once transfers are registered: Unknown
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
-
Details of transactions requiring disclosure
Date of transaction: 30 July 2025
Nature of transaction: On-market share sale
Name of any other party or parties to the transaction (if known): Not applicable.
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or
disposal. If the consideration was not in cash and cannot be readily by converted into a cash
value, describe the consideration:
$2.86 per share
Number of financial products to which the transaction related: 10,000 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period) include
—
the following details
Whether relevant interests were acquired or disposed of during a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed Not applicable
during the closed period:
Date of the prior written clearance (if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Ordinary shares
----- End of picture text -----
Nature of relevant interest:
Registered holder and beneficial owner 1,091 Robert Clyde McConaghy
- For that relevant interest, Number held in class: 1,091 Current registered holder(s): - For a derivative relevant interest, Type of derivative: Not applicable - Details of derivative, The notional value of the derivative (if any) or the notional amount of underlying financial Not applicable products (if any): A statement as to whether the derivative is cash settled or physically settled: Not applicable Maturity date of the derivative (if any): Not applicable Expiry date of the derivative (if any): Not applicable The price's specified terms (if any): Not applicable Any other details needed to understand how the amount of the consideration payable under Not applicable the derivative or the value of the derivative is affected by the value of the underlying financial products: - For that derivative relevant interest, Parties to the derivative: Not applicable If the director or senior manager is not a party to the derivative, the nature of the relevant Not applicable interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of person authorised to sign on behalf of director or officer: Date of signature: 1-Aug-25 Name and title of authorised person: Isla Dentice-Wood, Company Secretary